TB-500 supports systemic cell migration and wound healing
The peptide has not undergone the extensive clinical testing typically required for regulatory approval as a pharmaceutical treatment in the United States or European Union
The combination of growth hormone elevation and glucagon receptor activation creates two potential forces pushing glucose upward, and only GLP-1/GIP agonism pushes it down
The most common side effects are gastrointestinal, especially during dose escalation (e.g., nausea, constipation, diarrhea)
Collagen is the most abundant protein in the body the structural framework for skin, bones, cartilage, tendons, and connective tissue
Originally developed to treat type 2 diabetes, these drugs mimic the hormone GLP-1, helping regulate appetite and blood sugar